“You Gotta Generate Some Discipline Here”

Hims & Hers Health, Inc. (NYSE:Hims) is one of the 14 stocks Jim Cramer recently shared insights on. Discussing the importance of discipline over conviction, Cramer commented:

“No matter how much you love these speculative winners, you don’t have a gain until you actually ring the register. At the end of last week, for example, Hims & Hers Health, the online healthcare company, was trading at $64. But then yesterday, the stock fell 22 bucks for an almost 35% decline… What I care about is that this stock… [has] almost tripled in two months. If you owned Hims & Hers up almost 200% and you hadn’t sold any at that point, you were being a knucklehead.

A nurse in a telehealth platform talking with a patient on video call for consultation.

Hims & Hers Health (NYSE:HIMS) operates a telehealth platform that delivers prescription and non-prescription health and wellness products. The company’s products include medication, skin care, sexual health, hair care, and wellness items, supported by ongoing care from licensed healthcare professionals.

While we acknowledge the potential of HIMS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.